🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 5 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/03/2000 | 41,00 | 43,00 | 40,88 | 41,53 | +0,99% | 5,18% | 924.000 |
| 27/03/2000 | 46,06 | 46,50 | 37,50 | 41,13 | +17,29% | 19,54% | 2.064.000 |
| 24/03/2000 | 36,00 | 36,50 | 34,81 | 35,06 | -2,60% | 4,69% | 256.400 |
| 23/03/2000 | 36,00 | 36,38 | 35,00 | 36,00 | -1,03% | 3,82% | 121.000 |
| 22/03/2000 | 35,00 | 36,38 | 34,00 | 36,38 | +11,92% | 6,79% | 262.400 |
| 21/03/2000 | 29,31 | 37,38 | 29,13 | 32,50 | +13,79% | 28,14% | 505.800 |
| 20/03/2000 | 34,50 | 34,50 | 25,00 | 28,56 | -16,30% | 27,54% | 208.600 |
| 17/03/2000 | 34,00 | 35,00 | 34,00 | 34,13 | -2,50% | 2,94% | 225.000 |
| 16/03/2000 | 37,31 | 37,31 | 34,75 | 35,00 | +2,56% | 6,87% | 128.000 |
| 15/03/2000 | 39,25 | 40,50 | 34,03 | 34,13 | -13,33% | 16,48% | 389.000 |
| 14/03/2000 | 43,81 | 43,81 | 39,19 | 39,38 | -10,51% | 10,56% | 554.000 |
| 13/03/2000 | 46,75 | 46,75 | 44,00 | 44,00 | -5,25% | 5,88% | 216.800 |
| 10/03/2000 | 45,50 | 47,00 | 45,31 | 46,44 | +1,92% | 3,71% | 651.600 |
| 09/03/2000 | 45,75 | 46,00 | 45,13 | 45,56 | +0,14% | 1,91% | 657.200 |
| 08/03/2000 | 46,00 | 46,00 | 45,31 | 45,50 | -0,34% | 1,49% | 267.800 |
| 07/03/2000 | 45,50 | 46,13 | 45,00 | 45,66 | +1,46% | 2,47% | 377.800 |
| 06/03/2000 | 45,03 | 46,69 | 44,84 | 45,00 | -2,96% | 4,09% | 249.000 |
| 03/03/2000 | 49,31 | 50,13 | 44,44 | 46,38 | -6,14% | 11,53% | 428.400 |
| 02/03/2000 | 50,25 | 50,25 | 47,88 | 49,41 | -1,19% | 4,73% | 132.000 |
| 01/03/2000 | 50,00 | 50,25 | 48,50 | 50,00 | +2,56% | 3,50% | 261.400 |
| 29/02/2000 | 50,81 | 50,81 | 48,75 | 48,75 | -2,19% | 4,06% | 136.400 |
| 28/02/2000 | 50,63 | 51,25 | 49,25 | 49,84 | -1,42% | 3,95% | 234.200 |
| 25/02/2000 | 47,81 | 50,56 | 47,81 | 50,56 | +5,48% | 5,75% | 383.000 |
| 24/02/2000 | 48,25 | 48,25 | 46,38 | 47,94 | +0,52% | 3,89% | 186.000 |
| 23/02/2000 | 46,88 | 48,50 | 45,81 | 47,69 | +1,46% | 5,73% | 205.200 |
| 22/02/2000 | 47,06 | 48,97 | 46,00 | 47,00 | +0,40% | 6,31% | 142.000 |
| 18/02/2000 | 46,50 | 47,88 | 45,88 | 46,81 | +1,77% | 4,30% | 282.600 |
| 17/02/2000 | 43,50 | 47,19 | 43,38 | 46,00 | +4,40% | 8,76% | 519.000 |
| 16/02/2000 | 42,25 | 45,00 | 42,25 | 44,06 | +4,21% | 6,51% | 452.000 |
| 15/02/2000 | 39,63 | 43,19 | 39,63 | 42,28 | +6,03% | 8,99% | 352.000 |